Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18843862 | 0.94 | PLA2G2C (0.41) | GAACYP3A4CYP2C9CYP2C19PLA2G2C | |
| SCHEMBL12232688 | 0.88 | MEN1 (0.44) | GAACYP3A4CYP2C9CYP2C19PLA2G2C | |
| SCHEMBL24637862 | 0.85 | GAA (0.42) | GAACYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL5273087 | 0.85 | CYP1A2 (0.41) | GAACYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL3316311 | 0.85 | GAA (0.39) | GAACYP3A4CYP2C9CYP2C19PLA2G2C | |
| SCHEMBL24637996 | 0.85 | GAA (0.35) | GAACYP3A4CYP2C9CYP2C19PLA2G2C | |
| SCHEMBL12232709 | 0.84 | GAA (0.43) | GAACYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL18843881 | 0.84 | PLA2G4A (0.36) | GAACYP3A4CYP2C9CYP2C19PLA2G2C | |
| SCHEMBL2543782 | 0.81 | GAA (0.41) | GAACYP3A4CYP2C9CYP2C19PLA2G2C | |
| SCHEMBL5276735 | 0.81 | GAA (0.41) | GAACYP3A4CYP2C9CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024714-A2 | BONE-TARGETED CANONICAL NOTCH INHIBITOR | BIOVENTURES, LLC (US) | 2025-01-30 | — | — | WO | disclosed |
| US-10660884-B2 | Phosphonate-chloroquine conjugates and methods using same | UNIVERSITY OF ROCHESTER (US) | 2020-05-26 | — | — | US | disclosed |
| US-20160248025-A1 | Organic Electroluminescent Device | UDC IRELAND LTD (IE) | 2016-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660884-B2 | Phosphonate-chloroquine conjugates and methods using same | PHPT1, ENPP2, QPCT | GAA 71/4885CYP3A4 4483/4885CYP2C9 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.